Onderneming StemCells Inc Nasdaq
Aandelen
US85857R3030
Biotechnologie & Medisch Onderzoek
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 02-08-88 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 01-01-22 |
Chief Tech/Sci/R&D Officer | - | 01/12 | |
Simon Sharon
CTO | Chief Tech/Sci/R&D Officer | 64 | 05-04-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 28-11-16 |
Director/Board Member | 66 | 12-12-17 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 01-08-20 |
Harel Gadot
CEO | Chief Executive Officer | 52 | 02-08-88 |
Yossi Bornstein
FOU | Founder | 66 | 02-08-88 |
Martin Madden
BRD | Director/Board Member | 64 | 06-02-17 |
Director/Board Member | 62 | 01-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 14 398 964 | 14 156 936 ( 98,32 %) | 0 | 98,32 % |
Bedrijfsgegevens
Microbot Medical, Inc.
288 Grove Street Suite 388
02184, Braintree
+781 875 3605
http://microbotmedical.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,28% | 46,81 mld. | |
-1,06% | 41,37 mld. | |
+47,07% | 41,29 mld. | |
-3,52% | 28,87 mld. | |
+11,69% | 26,06 mld. | |
-19,77% | 19,13 mld. | |
+32,46% | 12,39 mld. | |
+0,33% | 12,08 mld. | |
-0,52% | 11,96 mld. |